Skip to main content
Larkosis Pharma Logo
Ofloxacin Extended Release

Category

Antibacterial (Fluoroquinolone)

Form

Extended Release Tablets

Strength

400mg

CAS

82419-36-1

Ofloxacin Extended Release Tablets – Once-Daily Sustained Antibacterial Therapy

Extended-release fluoroquinolone antibacterial. Once-daily dosing for improved compliance. Controlled drug release for sustained effect. High bioavailability and stable plasma levels. Manufactured under international pharmaceutical standards.

Ofloxacin Extended Release Tablets are an advanced antibacterial formulation designed for improved pharmacokinetics and patient convenience. They belong to the fluoroquinolone class and offer broad-spectrum antibacterial activity. Identified by CAS Number 82419-36-1, they ensure reliable and consistent clinical outcomes. The extended-release technology maintains stable drug concentrations over time. Manufactured under strict global pharmaceutical quality standards.

Request Quote

Overview

  • Extended-release fluoroquinolone antibiotic.
  • Inhibits bacterial DNA gyrase and topoisomerase IV.
  • Provides sustained antibacterial effect.
  • Improves patient compliance with once-daily dosing.
  • Used in global healthcare systems.

Introduction

  • Ofloxacin Extended Release Tablets are an advanced antibacterial formulation designed for improved pharmacokinetics and patient convenience.
  • They belong to the fluoroquinolone class and offer broad-spectrum antibacterial activity.
  • Identified by CAS Number 82419-36-1, they ensure reliable and consistent clinical outcomes.
  • The extended-release technology maintains stable drug concentrations over time.
  • Manufactured under strict global pharmaceutical quality standards.

Important Information

  • Belongs to fluoroquinolone antibacterial class.
  • CAS 82419-36-1 ensures traceability.
  • Available as 400mg extended-release tablets.
  • Once-daily oral dosage form (10 x 10’s packaging).
  • Requires medical supervision.

Dosage

General

  • Typical dose: 400mg once daily
  • Severe infections: as prescribed by physician
  • Duration: typically 5–10 days
  • Adjust dose in renal impairment

Administration

  • Swallow whole – do not crush or chew
  • Take with a full glass of water
  • Can be taken with or without food
  • Avoid antacids or dairy near dosing

Important

  • Complete full prescribed course
  • Do not skip doses
  • Do not alter extended-release tablet

Storage

  • Store below 25°C
  • Protect from moisture and sunlight
  • Keep in original packaging
  • Keep out of reach of children

Shelf Life

  • Typical shelf life: 24–36 months
  • Check expiry before use
  • Proper storage maintains stability

Manufacturing

  • Manufactured in WHO-GMP certified facilities
  • High-quality API (CAS 82419-36-1)
  • Advanced extended-release formulation technology
  • Controlled drug release system
  • Strict quality control processes

Precautions

  • Avoid in fluoroquinolone hypersensitivity
  • Use cautiously in elderly patients
  • Monitor kidney function
  • Avoid prolonged unnecessary use
  • Avoid excessive sunlight exposure
  • Do not crush or chew tablets
  • Not recommended during pregnancy unless prescribed

Side Effects

  • Nausea
  • Vomiting
  • Diarrhea
  • Headache
  • Dizziness
  • Insomnia
  • Photosensitivity
  • Rare tendon inflammation or rupture
  • Allergic reactions

Expert View

  • Advanced antibacterial formulation.
  • Improves compliance with once-daily dosing.
  • Ensures sustained drug levels.
  • Widely accepted in modern clinical practice.
  • Reliable for outpatient therapy.

Indications

  • Respiratory tract infections
  • Urinary tract infections (UTIs)
  • Gastrointestinal infections
  • Skin and soft tissue infections
  • Prostatitis
  • Sinus infections

Maintenance

  • Complete full antibiotic course
  • Once-daily dosing improves adherence
  • Monitor patient response
  • Adjust dose if required
  • Follow physician guidance

Why Choose

  • Once-daily convenience
  • Advanced extended-release technology
  • WHO-GMP certified manufacturing
  • Global export-quality standards
  • Consistent therapeutic outcomes

Frequently Asked Questions

Common product and supply questions.

What is the use of ofloxacin extended release tablet?+

Ofloxacin Extended Release Tablets are used to treat respiratory, urinary, and gastrointestinal bacterial infections with once-daily sustained action.

What is ofloxacin 400 mg used for?+

Ofloxacin 400 mg is used for moderate to severe infections such as pneumonia, UTIs, and bacterial diarrhea.

Can I take ofloxacin 400 mg twice a day?+

Ofloxacin Extended Release 400 mg is usually taken once daily and should not be taken twice unless prescribed.

What are the different forms of ofloxacin available?+

Ofloxacin is available as tablets, extended-release tablets, eye drops, ear drops, and injections.

Which one is better, ciprofloxacin or ofloxacin?+

The choice depends on infection type and bacterial sensitivity; both are effective antibiotics.